Cannaus
  • Home
  • State News
    • ACT
    • QLD
    • NSW
    • NT
    • SA
    • TAS
    • VIC
    • WA
  • Topics
    • Business
    • CBD
    • Government
    • Hemp
    • International
    • Legalisation
    • Medicinal Cannabis
    • Offences
    • Research
    • Misc
  • Cannabis Companies
No Result
View All Result
Cannaus

Cann Global and WSU launch study to see if medicinal cannabis slows the progression of MS

4 years ago
in National
0
Scientist researching cannabis leaves

Scientist researching cannabis leaves

Share on FacebookShare on Twitter

Medical cannabis company Cann Global (ASX:CGB) has announced a new research partnership that will see them studying medicinal cannabis as a treatment to slow the progression of Multiple Sclerosis (MS).

MS is a condition that affects the body’s central nervous system and interferes with nerve impulses in the eyes, spinal cord and brain. It currently affects over 25,600 Australians. Medicinal cannabis is frequently used to control the symptoms of MS, which include vertigo, depression, loss of motor control, incontinence, heat sensitivity, and muscular spasms. 

Cann Global has been investing in MS research for some time, and completed a landmark study on mice last year. Lead by Dr. Dedi Meiri from Technion, researchers in the study were able to use a unique medicinal cannabis strain to slow the progression of MS, as well reverse some of the damage MS had caused to the bodies of the mice. The study was conducted in Israel, which is renowned for its cannabis research.

Drawing inspiration from the mice-with-MS study, Cann Global has entered into a binding agreement with Western Sydney University’s NICM Health Research Institute. Together, they will launch a clinical trial that will treat people suffering from MS with the unique medicinal cannabis strain. 

Cann Global has chosen to conduct the study with NICM because they are recognised for their world-class research. The facility is partially funded by the Commonwealth and the NSW Governments. NICM is also working on an Alzheimer’s trial with medicinal cannabis company ANTG. 

According to comments made by executive chairperson Pnina Feldman after the mice-with-MS study, developing treatments for MS is a part of Cann Global’s long-term vision. 

We are looking forward to the exciting times ahead and are thrilled to be a part of the ground-breaking research in the use of medical cannabis as a potential treatment for autoimmune diseases.

Over the next few months, NICM and Cann Global will develop a clinical trial protocol for their MS and medicinal cannabis study. This will be released to shareholders before the study commences.

Tags: Research
Share4Tweet3
Karie Cornell

Karie Cornell

Based in Victoria, Karie's passionate about pro-cannabis legislation in Australia. She joined Cannaus to share and bring awareness to the latest cannabis news across Australia.

Related Posts

Cannabis leaf with seeds
National

WA government classifies a cannabis seed the same as a fully-grown plant

January 13, 2022
Small cannabis plant growing in a pot
National

New Zealand-based cannabis producer Greenfern reaches partnership agreement with Cannvalate

January 13, 2022
Cannabis medicine
National

Study shows the majority of women using medical cannabis for endometriosis obtain it illegally

January 11, 2022
Green cannabis leaf on wood
National

Cannim set to become major name in adult-use cannabis market through strategic merger

December 27, 2021
Cannabis oil with bud
National

Elixinol Wellness (ASX: EXL) signs deal with major British cannabis company

December 27, 2021
Penalty
National

TGA fines St Francis Pharmacy nearly $40k for advertising medicinal cannabis

December 23, 2021
Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Weekly Cannabis News

Get the latest Australian cannabis news straight to your inbox every week.

Enter your email address
  • Home
  • Contact
  • Privacy Policy

Disclaimer
Cannaus does not recommend that anyone uses cannabis for medical or adult use purposes unless consulted by a medical professional. Cannabis is a drug and may have negative side effects. Please consult with your doctor to find out if cannabis is right for you.

  • Home
  • State News
    • ACT
    • QLD
    • NSW
    • NT
    • SA
    • TAS
    • VIC
    • WA
  • Topics
    • Business
    • CBD
    • Government
    • Hemp
    • International
    • Legalisation
    • Medicinal Cannabis
    • Offences
    • Research
    • Misc
  • Cannabis Companies
No Result
View All Result
Weekly Cannabis News

Get the latest Australian cannabis news straight to your inbox every week.

Enter your email address

Thanks, I’m not interested

wpDiscuz